市场调查报告书
商品编码
1400702
全球 MRI 市场评估:按场强、按设计、按应用、按最终用户、按地区、机会、预测(2017-2031 年)Magnetic Resonance Imaging Market Assessment, By Field Strength, By Design, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球MRI市场规模预计到2023年将达到74亿美元,2031年将达到115.1亿美元,2024-2031年预测期间复合年增长率为5.68%。近年来,在重要因素和显着技术创新的共同推动下,市场呈现显着成长。市场扩张的主要因素是新兴国家老年人口的增加、慢性病盛行率的增加、新技术的引进、安装的增加和意识的提高。
电脑科学、数据处理和半导体等各领域的新技术正迅速成为 MRI 技术进步的关键。这种整合导致了创新应用程式的创建。由于 HPC 和 MRI 技术进步的协同效应,MRI 现在能够产生大量的功能和解剖成像数据,成为多种疾病的重要资源。MRI 机器成本高、MRI 技术人员短缺等因素对市场产生负面影响。
该市场呈现显着成长,主要是由于老年人口的增加和慢性病盛行率的增加。近年来,老年人口大幅增加,越来越多的老年人寻求咨询和诊断服务。随着年龄的增长,我们对各种健康问题的敏感度增加,包括心血管疾病、癌症和神经系统疾病等慢性疾病。到 2030 年,世界上六分之一的人将年龄在 60 岁或以上。在此期间,全球60岁及以上人口比例将从2020年的10亿增加到14亿。到2050年,全球60岁及以上的人口预计将增加一倍,达到21亿。此外,预计 2020 年至 2050 年间,80 岁及以上的人口数量将增加两倍,达到 4.26 亿。事实证明,MRI 技术对于这些疾病的早期检测、准确诊断和监测非常有用。MRI 是医疗专业人员的首选,因为它是非侵入性的并且提供高解析度成像。MRI 有助于检测动脉瘤、眼/耳疾病、中风、肿瘤、脑损伤和韧带损伤等疾病。因此,随着医疗保健提供者和患者认识到技术在改善患者治疗结果和支持更有效的医疗保健管理方面的作用,对 MRI 技术的需求正在迅速增加。
MRI 技术的进步正在加速市场创新。高场 MRI 扫描仪、多参数成像和人工智慧影像分析等新发展显着提高了影像品质和诊断准确性。此外,功能性 MRI (fMRI) 和扩散张量成像 (DTI) 的整合正在开启理解大脑功能和连接性的新可能性,有助于神经系统疾病的诊断和治疗。此外,MRI 机器的小型化和便携式系统的出现使偏远和服务不足的地区更容易使用这种诊断工具。
目前,高场强MRI和超高场强MRI技术占据市场主导地位。这些先进的 MRI 系统提供高影像分辨率,可进行更精确和详细的诊断。高场MRI(通常在1.5 特斯拉或3 特斯拉下运行)已成为各种临床应用的标准,而超高场MRI(在4 特斯拉或更高的功率下运行)正在研究和专业临床环境中获得关注。 。这些强大的 MRI 系统有助于神经影像学、心血管研究和神经疾病研究,提供以前难以收集的宝贵见解。在高场强下工作的主要优点是提高讯号杂讯比和增强化学位移。高信噪比可用于减少扫描时间或提高空间分辨率,而不会影响诊断品质。
新兴国家的核磁共振设备安装量不断增加,为医疗基础设施带来了重大变化。这一增长可归因于医疗保健预算增加、中等收入人口不断增长以及对先进医学影像在早期诊断和治疗中重要作用的认识等因素。此外,这种扩张是由于医疗保健专业人员和公众对 MRI 在检测和监测各种医疗状况方面的好处的认识不断提高而推动的。MRI 服务的可用性增加了获得优质医疗照护的机会,从而实现更准确的诊断并改善患者的治疗结果。这一趋势反映了缩小已开发国家和新兴国家之间医疗保健差距的积极一步。
本报告研究和分析了全球 MRI 市场,提供市场规模和预测、市场动态、主要参与者的现状和前景等。
Global magnetic resonance imaging market size was valued at USD 7.4 billion in 2023, expected to reach USD 11.51 billion in 2031, with a CAGR of 5.68% for the forecast period between 2024 and 2031F. The global magnetic resonance imaging market has experienced substantial growth in recent years, driven by a convergence of key factors and fueled by remarkable innovations. Market expansion is primarily attributed to the growing geriatric population, increasing incidence of chronic diseases, introduction of novel technologies, and increasing installation and growing awareness in emerging countries.
Emerging technologies from different fields such as computer science, data processing, and semiconductors have quickly become integral to advancements in MRI technology. This integration has led to the creation of innovative applications. Through the synergies of high-performance computing and advancements in MRI technology, MRI can now generate extensive sets of both functional and anatomical image data, which serves as a vital resource across multiple diseases. Factors such as the high cost of MRI machines and the shortage of MRI technologists are negatively impacting the global magnetic resonance imaging (MRI) market.
The global magnetic resonance imaging market is experiencing substantial growth, largely driven by the growing geriatric population and the rising incidence of chronic diseases. The aging demographic has considerably increased in recent years, with more elderly individuals seeking medical attention and diagnostic services. As individuals age, their susceptibility to various health issues, including chronic diseases such as cardiovascular conditions, cancer, and neurological disorders, increases. By the year 2030, one out of every six individuals worldwide will have reached the age of 60 or older. During this period, the proportion of global population comprising those aged 60 and above will rise from 1 billion in 2020 to 1.4 billion. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double, reaching 2.1 billion. Furthermore, the number of people aged 80 or older is anticipated to triple between 2020 and 2050, reaching 426 million. MRI technology has proven valuable in the early disease detection, accurate diagnosis, and monitoring of these conditions. It offers non-invasive, high-resolution imaging, making it a preferred choice for healthcare professionals. MRI aids in detecting conditions such as aneurysm, eye/ear disorders, stroke, tumor, brain injuries, and ligament injuries. Consequently, the demand for MRI technologies has surged as healthcare providers and patients recognize technology's role in improving patient outcomes and ensuring more efficient healthcare management.
Advancements in MRI technologies have accelerated innovation in the global magnetic resonance imaging (MRI) market. Novel developments, such as higher-field MRI scanners, multi-parametric imaging, and AI-driven image analysis, have significantly improved image quality and diagnostic accuracy. Furthermore, the integration of functional MRI (fMRI) and diffusion tensor imaging (DTI) has unlocked new possibilities in understanding brain function and connectivity, aiding in the diagnosis and treatment of neurological conditions. Additionally, the miniaturization of MRI machines and the advent of portable systems have made this diagnostic tool more accessible, even in remote or underserved regions.
In September 2023, the FDA granted regulatory approval for IGAR, a robotics system created by Insight Medbotics, making it the first and only robotic platform specifically engineered to operate within the MRI bore. The pioneering technology, IGAR, has the potential for future adaptations to function in various hospital settings. Insight Medbotics has showcased the safety and effectiveness of IGAR through publicly available clinical studies focused on breast biopsy procedures.
At the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2023 Annual Meeting, GE Healthcare introduced its SIGNA PET/MR AIR. During the event, the company presented the incorporation of its state-of-the-art AIR technologies into the SIGNA PET/MR AIR system, aiming to improve diagnostic accuracy, streamline treatment assessment, and enhance the overall comfort of patients.
High field strength MRI and ultra-high field strength MRI technologies are currently dominating the MRI market. These advanced MRI systems offer high image resolution, allowing for more precise and detailed diagnosis. High field MRI, typically operating at 1.5 Tesla or 3 Tesla, has become the standard for various clinical applications, while ultra-high field MRI, operating beyond 4 Tesla or higher, is gaining prominence in research and specialized clinical settings. These powerful MRI systems are instrumental in neuroimaging, cardiovascular studies, and research into neurological disorders, providing invaluable insights that were previously difficult to gather. The primary benefits of operating at high field strengths include an increased signal-to-noise ratio and enhanced chemical shift. High signal-to-noise ratio can be used to either reduce scanning time without compromising diagnostic quality or to enhance spatial resolution.
In February 2023, A group of seven organizations, led by the Donders Institute of Brain, Cognition, and Behavior, has been awarded EUR 19 million roadmap grant from the Dutch Research Council. This funding will be dedicated to the development of the world's inaugural 14 Tesla MRI scanner. The heightened sensitivity of this scanner will enable researchers to achieve more comprehensive brain imaging, leading to an improved understanding of brain function. Additionally, it will provide fresh insights into disease mechanisms and their treatment across the entire human body.
The installation of MRI machines is on the rise in emerging countries, marking a significant shift in healthcare infrastructure. The increase can be attributed to several factors, including rising healthcare budgets, a growing middle-class population, and the recognition of the vital role that advanced medical imaging plays in early diagnosis and treatment. Additionally, the growing awareness among healthcare professionals and the public about the benefits of MRI in detecting and monitoring various medical conditions has driven this expansion. The availability of MRI services is improving access to high-quality healthcare, allowing for more accurate diagnosis and better patient outcomes. This trend reflects a positive step towards bridging the healthcare gap between developed and emerging nations.
The global magnetic resonance imaging (MRI) market experienced significant impacts due to the COVID-19 pandemic. Initially, as healthcare resources were diverted towards managing the pandemic, non-essential medical procedures, including elective MRI scans, were postponed or canceled to prioritize COVID-19 patients. It led to a temporary downturn in MRI utilization and revenue for many healthcare facilities. However, the pandemic highlighted the importance of advanced diagnostic imaging in healthcare. As COVID-19 cases surged, MRI played a crucial role in assessing the extent of lung damage and monitoring patients' conditions. Moreover, the awareness of the need for faster and more efficient MRI diagnosis for COVID-19-related complications led to innovations in MRI technology. In the post-COVID-19 era, there has been a notable surge in the utilization of AI and machine learning in MRI, revolutionizing the field of medical imaging. These technologies are enhancing diagnostic accuracy, automating image analysis, and expediting the interpretation of MRI scans.
The global magnetic resonance imaging market features a landscape dominated by key players such as GE Healthcare Technologies Inc., Canon Medical System Corporation, Koninklijke Philips N.V, Siemens Healthineers AG, Hitachi Ltd, Aurora Imaging Technologies Inc., Fujifilm Holdings Corporation, and others. Companies are enhancing their imaging capabilities by manufacturing MRI scanners that have ultra-high field strength by surpassing the old high field strength of 3 Tesla. Market players are designing MRI scanners that are open or have wide bore for patients that are claustrophobic. Market players are developing partnerships to reach emerging markets.
In September 2023, Siemens Healthineers announced the FDA approval of Magnetom Viato.Mobile, a novel 1.5 Tesla (1.5T) magnetic resonance (MR) imaging scanner. This MRI scanner is specially designed for mobile applications, offering increased versatility for deploying MR imaging. It can be conveniently set up on a trailer, facilitating transportation to remote locations, thus extending the accessibility of advanced medical imaging to patients, including those with significant health issues, who would otherwise face long journeys for such services.
In October 2023, Philips announced its collaboration with Quibim to introduce advanced AI-driven imaging software aimed at prostate cancer detection. By combining Philips' innovative AI-enhanced MR imaging software with Quibim's AI-powered image analysis software, healthcare providers can expedite and simplify prostate cancer diagnosis and care.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work